Assessment of the Membranous Labyrinth in Infants Using a Heavily T2-weighted 3D FLAIR Sequence without Contrast Agent Administration

References

1. 1.↵
   1. Morton CC,
   2. Nance WE

   . Newborn hearing screening–a silent revolution. N Engl J Med 2006;354:2151–64 doi:10.1056/NEJMra050700 pmid:16707752

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Korver AMH,
   2. Smith RJH,
   3. Van Camp G, et al

   . Congenital hearing loss. Nat Rev Dis Primers 2017;3:16094 doi:10.1038/nrdp.2016.94 pmid:28079113

   CrossRefPubMed
3. 3.↵
   1. Grosse SD,
   2. Ross DS,
   3. Dollard SC

   . Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol 2008;41:57–62 doi:10.1016/j.jcv.2007.09.004 pmid:17959414

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Marazita ML,
   2. Ploughman LM,
   3. Rawlings B, et al

   . Genetic epidemiological studies of early-onset deafness in the U.S. school-age population. Am J Med Genet 1993;46:486–91 doi:10.1002/ajmg.1320460504 pmid:8322805

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Smith RJH,
   2. Bale JF Jr.,
   3. White KR

   . Sensorineural hearing loss in children. Lancet 2005;365:879–90 doi:10.1016/S0140-6736(05)71047-3 pmid:15752533

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Snoeckx RL,
   2. Huygen PLM,
   3. Feldmann D, et al

   . GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet 2005;77:945–57 doi:10.1086/497996 pmid:16380907

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Yoshinaga-Itano C,
   2. Sedey AL,
   3. Coulter DK, et al

   . Language of early- and later-identified children with hearing loss. Pediatrics 1998;102:1161–71 doi:10.1542/peds.102.5.1161 pmid:9794949

   Abstract/FREE Full Text
8. 8.↵
   American Academy of Pediatrics, Joint Committee on Infant Hearing. Year 2007 position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics 2007;120:898–921 doi:10.1542/peds.2007-2333 pmid:17908777

   FREE Full Text
9. 9.↵
   1. Parry DA,
   2. Booth T,
   3. Roland PS

   . Advantages of magnetic resonance imaging over computed tomography in preoperative evaluation of pediatric cochlear implant candidates. Otol Neurotol 2005;26:976–82 doi:10.1097/01.mao.0000185049.61770.da pmid:16151346

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Casselman JW,
    2. Kuhweide R,
    3. Ampe W, et al

    . Inner ear malformations in patients with sensorineural hearing loss: detection with gradient-echo (3DFT-CISS) MRI. Neuroradiology 1996;38:278–86 doi:10.1007/BF00596549 pmid:8741202

    CrossRefPubMed
11. 11.↵
    1. Ellul S,
    2. Shelton C,
    3. Davidson HC, et al

    . Preoperative cochlear implant imaging: is magnetic resonance imaging enough? Am J Otol 2000;21:528–33 pmid:10912699

    PubMedWeb of Science
12. 12.↵
    1. Carfrae MJ,
    2. Holtzman A,
    3. Eames F, et al

    . 3 Tesla delayed contrast magnetic resonance imaging evaluation of Ménière’s disease. Laryngoscope 2008;118:501–05 doi:10.1097/MLG.0b013e31815c1a61 pmid:18091332

    CrossRefPubMed
13. 13.↵
    1. Conte G,
    2. Lo Russo FM,
    3. Calloni SF, et al

    . MR imaging of endolymphatic hydrops in Ménière’s disease: not all that glitters is gold. Acta Otorhinolaryngol Ital 2018;38:369–76 doi:10.14639/0392-100X-1986 pmid:30197428

    CrossRefPubMed
14. 14.↵
    1. Fumagalli M,
    2. Cinnante CM,
    3. Calloni SF, et al

    . Clinical safety of 3-T brain magnetic resonance imaging in newborns. Pediatr Radiol 2018;48:992–98 doi:10.1007/s00247-018-4105-0 pmid:29594440

    CrossRefPubMed
15. 15.↵
    1. Conte G,
    2. Caschera L,
    3. Tuscano B, et al

    . Three-Tesla magnetic resonance imaging of the vestibular endolymphatic space: a systematic qualitative description in healthy ears. Eur J Radiol 2018;109:77–82 doi:10.1016/j.ejrad.2018.10.023 pmid:30527315

    CrossRefPubMed
16. 16.↵
    1. Bernaerts A,
    2. Vanspauwen R,
    3. Blaivie C, et al

    . The value of four stage vestibular hydrops grading and asymmetric perilymphatic enhancement in the diagnosis of Menière’s disease on MRI. Neuroradiology 2019;61:421–29 doi:10.1007/s00234-019-02155-7 pmid:30719545

    CrossRefPubMed
17. 17.↵
    1. Streeter GL

    . On the development of the membranous labyrinth and the acoustic and facial nerves in the human embryo. Am J Anat 1906;6:139–65 doi:10.1002/aja.1000060103

    CrossRefWeb of Science
18. 18.↵
    1. Naganawa S,
    2. Kawai H,
    3. Sone M, et al

    . Increased sensitivity to low concentration gadolinium contrast by optimized heavily T2-weighted 3D-FLAIR to visualize endolymphatic space. MRMS 2010;9:73–80 doi:10.2463/mrms.9.73 pmid:20585197

    CrossRefPubMed
19. 19.↵
    1. Conte G,
    2. Caschera L,
    3. Calloni S, et al

    . MR imaging in Menière disease: is the contact between the vestibular endolymphatic space and the oval window a reliable biomarker? AJNR Am J Neuroradiol 2018;39:2114–19 doi:10.3174/ajnr.A5841 pmid:30337432

    Abstract/FREE Full Text
20. 20.↵
    1. Sepahdari AR,
    2. Ishiyama G,
    3. Vorasubin N, et al

    . Delayed intravenous contrast-enhanced 3D FLAIR MRI in Meniere’s disease: correlation of quantitative measures of endolymphatic hydrops with hearing. Clin Imaging 2015;39:26–31 doi:10.1016/j.clinimag.2014.09.014 pmid:25457542

    CrossRefPubMed
21. 21.↵
    1. Naganawa S,
    2. Yamazaki M,
    3. Kawai H, et al

    . Visualization of endolymphatic hydrops in Ménière’s disease with single-dose intravenous gadolinium-based contrast media using heavily T2-weighted 3D-FLAIR. Magn Reson Med Sci 2010;9:237–42 doi:10.2463/mrms.9.237 pmid:21187694

    CrossRefPubMed
22. 22.↵
    1. Tagaya M,
    2. Teranishi M,
    3. Naganawa S, et al

    . 3 Tesla magnetic resonance imaging obtained 4 hours after intravenous gadolinium injection in patients with sudden deafness. Acta Otolaryngol 2010;130:665–69 doi:10.3109/00016480903384176 pmid:19958242

    CrossRefPubMed
23. 23.↵
    1. Nakashima T,
    2. Naganawa S,
    3. Teranishi M, et al

    . Endolymphatic hydrops revealed by intravenous gadolinium injection in patients with Ménière’s disease. Acta Otolaryngol 2010;130:338–43 doi:10.3109/00016480903143986 pmid:19685358

    CrossRefPubMed
24. 24.↵
    1. Lane JI,
    2. Witte RJ,
    3. Bolster B, et al

    . State of the art: 3T imaging of the membranous labyrinth. AJNR Am J Neuroradiol 2008;29:1436–40 doi:10.3174/ajnr.A1036 pmid:18388217

    Abstract/FREE Full Text
25. 25.↵
    1. Maloney E,
    2. Iyer RS,
    3. Phillips GS, et al

    . Practical administration of intravenous contrast media in children: screening, prophylaxis, administration and treatment of adverse reactions. Pediatr Radiol 2019;49:433–47 doi:10.1007/s00247-018-4306-6 pmid:30923875

    CrossRefPubMed
26. 26.↵
    1. Conte G,
    2. Scola E,
    3. Calloni S, et al

    . Flat panel angiography in the cross-sectional imaging of the temporal bone: assessment of image quality and radiation dose compared with a 64 section multisection CT scanner. AJNR Am J Neuroradiol 2017;38:1998–2002 doi:10.3174/ajnr.A5302 pmid:28751512

    Abstract/FREE Full Text
27. 27.↵
    1. Richard C,
    2. Courbon G,
    3. Laroche N, et al

    . Inner ear ossification and mineralization kinetics in human embryonic development—microtomographic and histomorphological study. Sci Rep 2017;7:4825 doi:10.1038/s41598-017-05151-0 pmid:28684743

    CrossRefPubMed
28. 28.↵
    1. Schmitt HA,
    2. Pich A,
    3. Schröder A, et al

    . Proteome analysis of human perilymph using an intraoperative sampling method. J Proteome Res 2017;16:1911–23 doi:10.1021/acs.jproteome.6b00986 pmid:28282143

    CrossRefPubMed